![Pritesh Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then served as the Chief Growth Officer at NovoCure Ltd. from 2022 to 2024.
Dr. Shah holds a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Tidigare kända positioner av Pritesh Shah
| Företag | Position | Slut |
|---|---|---|
| NOVOCURE LIMITED | Företagsledare/Principal | 2024-01-01 |
| OSI PHARMACEUTICALS, INC. | Försäljning & Marknadsföring | - |
Pritesh Shahs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
